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GENERAL INTRODUCTION 
Cori and Green, in 1943, reported that muscle glycogen phosphorylase 
could exist in two forms, namely phosphorylase ^ and phosphorylase The 
_b form depended entirely on AMP for activity while the a^ form did not. 
Phosphorylase a was shown to be enzymatically converted to the ^ form. 
They named the enzyme PR enzyme, in short for "prosthetic-group removing" 
enzyme (1), in thinking that phosphorylase ^ might contain tightly bound 
AMP. However, for years to come, no one could demonstrate that phos­
phorylase ^ contained stoichiometric amounts of AMP and that any nucleotide 
was released in the formation of phosphorylase Keller and Cori, in 
1953, observed that the enzymic conversion of phosphorylase ^ to ^ by PR 
enzyme also caused the phosphorylase ^ molecule to split into halves (2). 
So the name PR enzyme was then used in short for "phosphorylase-rupturing" 
enzyme. In 1955, Sutherland and Wosilait, working with the liver forms of 
glycogen phosphorylase, reported the enzymic conversion of phosphorylase a^ 
to ^ resulted in a release of inorganic phosphate (3), They named the 
enzyme responsible for the dephosphorylation of phosphorylase a_ 
inactivating enzyme, in short, IE enzyme. Because they did not observe any 
change in molecular size in the conversion of liver phosphorylase a^to 
phosphorylase and the liver phosphorylase ^ was not activated by AMP, 
it was uncertain whether IE enzyme was the same as the PR enzyme. Two 
years later, Fischer et showed that PR enzyme catalyzed the release of 
inorganic phosphate from muscle phosphorylase a^ in converting the a^ to the 
^ form (4). Later it was shown that seryl phosphate in the phosphorylase 
^ sequence was dephosphorylated in this reaction (5). The PR enzyme was 
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renamed phosphorylase phosphatase. The conversion of phosphorylase ^ to 
phosphorylase ^ was found to occur by an enzyme named phosphorylase kinase 
by Krebs and Fischer (6). In this reaction the transfer of phosphate from 
Mg-ATP into phosphorylase ^ was found to occur (6). Glycogen phosphorylase 
was the first enzyme shown to undergo covalent modification through 
phosphorylation-dephosphorylation. Later, another key enzyme in glycogen 
metabolism, glycogen syntase, was also shown to undergo phosphorylation-
dephosphorylation (7). A simplified pathway for the regulation of glycogen 
synthesis and degradation is shown in Figure 1. 
Comparatively little work was done in the sixties with phosphoprotein 
phosphatase than with its counterparts, phosphorylase kinase and cAMP-
dependent protein kinase. Part of this might be attributed to the earlier 
studies from Danforth et al_. (8). They concluded that conversion of 
phosphorylase ^ to a^ in the muscle following electric stimulation (or 
epinephrine administration) to the animal was due to an activation of 
phosphorylase kinase rather than to a change in phosphorylase phosphatase 
activity. Because hormonal effects seem to affect kinases, considerable 
attention was given to these enzymes and less to the phosphatases. In the 
late sixties and early seventies, there was a revived interest in phos­
phoprotein phosphatase because evidence for phosphatase regulation in the 
muscle was reported (9). The phosphoprotein phosphatase present in the 
protein-glycogen complex was found to undergo a rapid (10 seconds) 80% 
2+ inhibition in the presence of Mg-ATP and Ca and that inhibition was 
completely reversed after all the ATP had been exhausted. The mechanism 
by which the phosphatase is inhibited is not yet understood. One thing 
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Figure 1. Control of glycogen metabolism in mammalian tissues 
Table I 
Properties and substrates reported for Phosphoprotein Phosphatase preparations 
Tissue source Molecular weight Substrates^ Metal #fold 
and reference g20^ requirement purification 
Rabbit skeletal muscle 
Hurd et al- (10) 50,000 P —  —  —  2,000 
England et al. (11) —  —  —  P;Troponin I —  —  —  700 
Kato et al.~Tl2,13) 300,000 H;GS;P none —  —  —  
150,000 H;GS;P Mn^* for 
Huang & Glinsmann (14) 
H;GS only 
70,000 H;GS;P 
Morgan et al. (15) 72,000 myosin light Mg2+ 10,000 
chain 
Ray & England (16) 250,000 troponin I none —  — —  
20-50,000 H;P;Troponin I Mn for 
H only 
Antoniw et (17) 300,000 H —  —  —  
170,000 PK(a-subunit) 150 
75,000 PK(g-subunit) 
P;H;GS 
700 
Gratecos et al. (18) 32,000 P;Troponin I, T none 6,000 
Kato & Bishop (19) — P;H;GS — 1,000 
Brandt et (20) 35,000 P none 5,000 
)it liver 
Brandt et al. (20,21) 35,000 P;GS;PK(a&6);H;R none 24,700 
Khandelwal et (22) 30,500 GS;Troponin I none 4,600 
34,500 C-,P;H none 4,600 
Kobayashi et (23) 7.OS P;H - '— 23 
7.8S P;H —  —  —  35 
5.8S P;H 155 
^Abbreviations: P, phosphorylase a^; H, histone; GS, glycogen synthase; PK, phosphorylase 
kinase; C, casein; R, regulatory subunit of cAMP dependent protein kinase. 
Table  I .  (Cont inued)  
Tissue source Molecular weight 
and reference g20^ 
Rat liver 
Abe & Tsuiki (24) 500,000 
340,000 
115,000 
Titanji (25) 32,000 
Meisler & Langan (26) 190,000 
Dog liver 
Defreyn et al. (27) 51,000 
77,000 
138,000 
Dog heart 
Hsiao et al. (28) 156,000 
161,000 
95,000 
Li et (29) 35,000 
49,300 
61,000 
Bovine heart 
Nakai & Thomas (30) 70,000 
Chou et (31) 30,000 
Imaoka et aj[. (32) 250,000 
30,000 
Substrates® Metal 
requirement 
#fold 
purification 
GS 
GS 
GS 
H; Protamine} 
Pyruvate kinase 
H ; Protamine 
Mg" 
none 60 
P 
P 
P 
none 
none 
Mg2+ 
P;H 
P;H 
PiH 
P-,C-,H-,R 
C 
H 
none 
none 
none 
none 
Mn2+ 
10,000 
1,000 
1,000 
GS;P;HiC;PK 
R 
P;H 
P;H 
Mg^ for PK; 
C;H;GS only 
mil 
Mgf. 
Mg2+ 
200 
Table  I .  (Cont inued)  
Tissue source 
and reference 
Molecular weight Substrates' 
or S^^w 
Metal 
requirement 
#fQld 
purification 
Swine adipose tissue 
Miller et (33) 
Bovine adrenal cortex 
Ullman & Perlman (34) 
Bovine corpus-luteum plasma 
membrane 
Azar & Menon (35) 
55,000 
75,000 
130,000 
90,000 
PiTroponin I 
P;H;Protamine; 
p-nitrophenyl 
phosphate 
Protamine 
Protamine 
none 
Mn^* 
none 
none 
200 
500 
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is clear, however, and that is there is a synchronous regulation of the 
kinases and phosphatase to prevent futile cycling of ATP. 
In Table I, a list of partially or extensively purified phosphoprotein 
phosphatase from different mammalian tissues is given. Phosphoprotein 
phosphatase has also been found in ox spleen (36), ox brain (37), pigeon 
breast muscle (38), bovine spleen (39), ox brain membrane (40), rat brain 
(41), toad bladder (42), erythrocyte membrane (43), bovine anterior 
pituitary (44), tubulin preparation (45), renal brush border (46), 
synaptic membrane (47), bovine epididymal spermatozoa (48), chicken 
adipose tissue (49), sarcoplasmic reticulum (50), human myelin (51), 
bovine tracheal smooth muscle (52), acetylcholine rich receptor membrane 
(53), and rat thyroid (54). Thus, phosphoprotein phosphatase is found in 
all kinds of tissues, and is especially high in tissues not important for 
glycogen metabolism, such as adipose tissue, mammary gland and brain (55). 
Because of the wide substrate specificities of phosphoprotein 
phosphatase (Table I), it is likely that this enzyme is involved in the 
regulation of metabolic processes other than glycogen metabolism. As 
listed in Table I, phosphoprotein phosphatase has molecular weight 
ranging from 30,000 to 500,000. Some of the molecular weight species 
observed might be due to artifacts. Gratecos et (18) reported that 
the Mr=32,000 phosphatase prepared in their laboratory had a high tendency 
to aggregate into large molecular weight species. Mellgren et al. also 
2+ 
showed that there was a Ca -dependent neutral protease that degraded a 
Mr=260,000 phosphoprotein phosphatase into smaller forms (55). Even the 
speed of homogenization of tissue determined the size of phosphatase (57). 
8 
Among all this confusion, there seemed to be general agreement that a 
small molecular weight phosphoprotein phosphatase (Mr=35,000) could be 
obtained from the larger molecular weight species through 88% ethanol 
treatment, trypsin, 8M urea, or freeze and thaw with mercaptoethanol 
(13,16,28,30,32,57). The Mr=35,000 phosphatase is regarded as the 
catalytic subunit of the phosphoprotein phosphatase holoenzyme but no 
general agreement has been reached on the molecular size for the 
holoenzyme. In addition to the Mr=35,000 phosphatase catalytic subunit, 
Li et al_. (29) also reported a Mr=49,300 and Mr=61,000 phosphatase 
catalytic subunits, with different properties. Phosphoprotein phos­
phatase is specific for phosphoproteins. It will not dephosphorylate 
small molecular weight phosphate compounds like seryl phosphate and 
glycerophosphate, except one report indicates that it might dephos­
phorylate p-nitrophenyl phosphate (34). The pH optimum for the 
phosphatase is around 7.5, with Km for most phosphoprotein substrates in 
the low yM range (58). 
There has been a mystery about the metal requirement of this phos­
phoprotein phosphatase. Early report by Cori and Cori (59) indicated 
that phosphoprotein phosphatase in crude extract was activated 2-3 fold 
?+ by Mn but this activation was lost upon further enzyme purification (2), 
More recently, activation by divalent metal ions has been reported at 
different stages of purification of this phosphatase (36,20,60,61). Metal 
requirements differ from report to report as listed in Table I. Some of 
these are due to different preparations and to the different protein 
substrates used. Phosphoprotein such as phosphorylase a^are inhibited by 
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divalent cations, while most other phosphoproteins such as glycogen 
synthase, casein, histone, and g-subunit of phosphorylase kinase required 
divalent cations. Divalent cations caused a change in sedimentation 
value of phosphoprotein phosphatase from 7.8s to 4.1s in the crude extract 
(62) but no such effect on the extensively purified phosphatase (19,62, 
63). Phosphoprotein phosphatase was also shown to be inhibited by poly­
phosphate compounds such as nucleotide triphosphate and pyrophosphate, 
and could be reactivated by divalent metal ions (34,38,62,63,64,65). 
Kinetic studies by Martensen et (66) showed that there could be a 
metal binding site in phosphoprotein phosphatase. 
There are several well-defined classes of protein kinases, namely 
2+ 
cAMP-dependent, double-stranded RNA-dependent, cGMP-dependent, Ca -
dependent, and messenger-independent protein kinases (67). The question 
arises that whether there are specific phosphoprotein phosphatases as 
counterparts for each of these classes of protein kinases. The existence 
of specific phosphoprotein phosphatases have been suggested. Antoniw 
et (17) found a Mr=170,000 phosphatase highly specific for the a-
subunit of phosphorylase kinase, and a Mr=300,000 phosphatase for histone. 
Gratecos e^ (18) purified a Mr=32,000 phosphatase highly specific for 
phosphorylase and troponin. Li et aj_. (29) reported three forms of 
phosphatase Mr=35,000, 49,300, 61,000, with different substrate speci­
ficities and metal requirements. Maeno and Greengard (41) demonstrated 
four types of phosphatase in rat brain with different substrate 
specificities. There were multifunctional phosphoprotein phosphatases 
with wide substrate specificities as listed in Table I, These 
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multifunctional phosphoprotein phosphatases can be regulated by 
(a) competition between various phosphoprotein substrates for the enzyme, 
(b) the noncompetitive interaction of protein modifiers or other proteins 
with the phosphatase, (c) the specific interaction of ligands with the 
phosphoprotein substrates of the enzyme, i..£., by substrate-directed 
effects, (d) modification of the enzyme itself. Each of these will be 
discussed in detail in the following paragraphs. 
The first category of regulation can be illustrated by the 
inhibitory effect of phosphorylase ^ on the glycogen synthase phosphatase 
reaction in liver, as first elucidated by Hers and his collaborators (68, 
69). They showed a sequential inactivation of phosphorylase and activa­
tion of glycogen synthase in perfused rabbit liver or biopsies indicating 
a competitive phenomenon. Glycogen synthase activation from D-»-! only 
started after 90% of phosphorylase ^ had been converted to Kill ilea 
et al_. (70) also had evidence for coordinate control of liver glycogen 
synthase and phosphorylase by a single protein phosphatase. They showed 
that the cellular concentration of glycogen synthase and phosphorylase 
were 0.24 yM and 2 yM, respectively, and these values corresponded to the 
Km of the phosphatase for glycogen synthase and phosphorylase, being 
0.12 yM and 2 yM, respectively. The Vmax, on the other hand, for phos­
phorylase was found to be a hundred-fold higher than that for glycogen 
synthase. The higher Vmax value could explain why protein phosphatase 
could dephosphorylate phosphorylase five times faster than glycogen 
synthase in liver. Tan and Nuttall (71) observed only a simultaneous 
decrease in phosphorylase ^ and increase in glycogen synthase I in rat 
n 
liver by protein phosphatase and not a sequential phenomenon. The phos-
phorylated form of troponin (11), histone, protamine, casein (21,31,34) 
were also shown to be competitive inhibitors for the dephosphorylation of 
phosphorylase Bot and his collaborators found that the activated and 
nonactivated form of phosphorylase kinase were inhibitors for the dephos­
phorylation of phosphorylase ^ (72-74). They speculated on one of the 
possible reasons for the transient inhibition of the phosphorylase 
phosphatase during 'flash activation' (9,75). During 'flash activation', 
2+ Ca , cAMP, and Mg-ATP are added to a protein-glycogen pellet consisting 
of most of the enzymes involved in glycogen metabolism. Proteins phos-
phorylated by cANP-dependent protein kinase and phosphorylase kinase 
during 'flash activation' may serve as competitive inhibitors for the 
dephosphorylation of phosphorylase ^ (75). 
The second category of regulation of protein phosphatase is illus­
trated by the roles of the heat stable, trypsin labile protein inhibitors, 
first reported by Brandt et £j_* (76) in rabbit liver. Huang and Glinsmann 
(77-79) later found 2 types of heat stable, trypsin labile protein 
inhibitors in rabbit muscle. Type I inhibitor, Mr=26,000 was active 
towards phosphatase only after being phosphorylated by cAMP-dependent 
protein kinase. The phosphorylated type I inhibitor can be dephos-
2+ phorylated by a Mn dependent phosphatase. Type I inhibitor was found to 
be noncompetitive with phosphorylase a but had no effect with glycogen 
synthase or histone as substrates for the phosphatase (77). Type II 
inhibitor cannot be phosphorylated. It served as noncompetitive inhibitor 
for the dephosphorylation of phosphoproteins. The binding of type II 
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inhibitor to phosphatase can be reversed by dilution or trypsin (78,79). 
Type II inhibitor is not the same as the heat stable inhibitor for cAMP-
dependent protein kinase (79). The two types of heat stable protein 
inhibitors were further purified to near homogeneity by Cohen and his 
collaborators (80-82), Goriset^. (83), Nakai and Glinsmann (84), 
Khandelwal and Zinman (85). The amino acid analysis of type I inhibitor 
was found to be composed of 30% glutamate and proline. No tyrosine, 
tryptophan and cysteine were found (81). The inhibitor can be phos-
phorylated at a threonine residue and the sequence around the phosphory-
lated site is -ile-arg-arg-arg-arg-pro-thr-pro-ala-thr- (80). The 
P 
phosphorylated decapeptide can also serve as an inhibitor but it is 
2,000 times less effective than the type I inhibitor (81). Molecular 
weight of this inhibitor based on amino acid analysis was estimated to 
be 20,800 (81). The in vivo concentration of type I inhibitor is around 
1.5 yM in liver, which is very close to that of estimated cellular 
phosphatase concentration (81). Tissues rich in phosphatase such as the 
brain and adipose tissue are also high in heat stable protein inhibitors 
concentration (85). Glinsmann and collaborators observed that insulin 
treatment of diabetic rats caused a decrease in heat stable protein 
inhibitors and a simultaneous increase in phosphatase activity (86). They 
also reported that perfusion of rat hindlimb with adrenaline inhibited 
protein phosphatase activity with an increase in type I heat stable 
phosphatase inhibitor (87). Thus, it seems cAMP-dependent protein kinase 
can affect both phosphorylase kinase and phosphoprotein phosphatase 
indirectly through a phosphorylatable inhibitor protein and these 
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processes could account for regulation during 'flash activation' (9) or 
epinephrine treatment. Also, there is one report by Defreyn et al^. (88) 
that there is a deinhibitor protein neutralizing the effect of the heat 
stable phosphatase inhibitors on dog liver phosphoprotein phosphatase. 
Thus, more proteins are likely involved and much needs to be done to 
understand these regulatory processes. 
Regulation of the multifunctional phosphatase by substrate directed 
effects (third category) can be illustrated by the following examples. 
The phosphorylation of the g-subunit of phosphorylase kinase correlates 
with the enzyme activity and is faster than the phosphorylation of the 
a-subunit. Cohen and Antoniw (89) showed that the phosphorylation of the 
a-subunit increases the dephosphorylation of the g-subunit by the multi-
2+ functional Mr=75,000, Mn -dependent phosphatase with a simultaneous 
decrease in phosphorylase kinase activity. So for multi-sites 
phosphorylated proteins, the phosphorylation of one site can regulate the 
dephosphorylation of another site. Holmes and Mansour reported that 
glucose, glycogen and glucose-6-phosphate activated the dephosphorylation 
of phosphorylase in rat diaphragm (90). AMP, caffeine, and spermine, in 
addition to glucose, glycogen and glucose-6-phosphate were shown to 
modify the dephosphorylation of phosphorylase a^ through substrate directed 
effects (19,66,91-93). Glucose-6-phosphate activated, while glycogen and 
ATP inhibited the dephosphorylation of glycogen synthase. These effectors 
were found to affect the glycogen synthase conformation (94-100). The 
substrate-directed effects on the rate of phosphorylation-dephosphorylation 
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of the key enzymes involved in glycogen metabolism enables the glycogen 
metabolism to tie in with other metabolism in the cell. 
The fourth category of regulation of the multifunctional phosphatase 
is through modification of the phosphatase itself. One of the possible 
methods has been discussed earlier, 1-^., polyphosphate compounds such as 
nucleotide triphosphates and pyrophosphate can inactivate phosphoprotein 
phosphatase and inactivation can be reversed by divalent metal ions such 
as Mg^*, and Co^*. Phosphoprotein phosphatase was shown to exist as 
a holoenzyme with a catalytic subunit of molecular weight anywhere from 
35,000 to 49,300 (16,32,57,101,102). In vitro studies showed that the 
holoenzyme could be converted to the catalytic subunit with harsh treat­
ments such as 88% ethanol, 8M urea, and freeze-thaw, with a simultaneous 
increase in phosphatase activity and change in properties such as metal 
requirements and substrate specificities. There is no convincing study 
showing how or whether in vivo the phosphoprotein phosphatase is 
converted from one form to the other. 
In my thesis work, I chose to look carefully into two of the 
categories mentioned above of how multifunctional phosphatase is being 
regulated. I used a form of protein phosphatase (Mr=35,000) that was 
obtained from rabbit liver. I investigated (a) possible mechanisms of 
how polyphosphate compounds such as ATP and pyrophosphate inactivate 
protein phosphatase and how divalent metals reactivate the inactivated 
phosphatase; (b) role of the coenzyme, pyridoxal phosphate of phos-
phorylase ^ in affecting the substrate-directed effects towards the 
rate of dephosphorylation of phosphorylase a^. 
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Explanation of Dissertation Format 
This dissertation follows an alternate format in which there are 
two sections after the General Introduction. Each of the two sections 
has been submitted to the Journal of Biological Chemistry. 
In the first section, all the experiments were carried out by 
the author with helpful discussion from Dr. D. J. Graves. In the 
second section, the pyridoxal phosphate analogs were synthesized by 
Dr. D. E. Metzler's laboratory. R. J. Uhing improved the method of 
preparing apo-phosphorylase. R. F. Parrish did some of the 
preliminary experiments. The author was responsible for the kinetic 
analysis and the ultracentrifugation studies of the pyridoxal 
phosphate analogs reconstituted phosphorylase. 
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SECTION I: INACTIVATION AND REACTION OF PHOSPHOPROTEIN PHOSPHATASE 
18 
Inactivation and Reactivation of 
Phosphoprotein Phosphatase 
Sau-chi Betty Van 
Donald J. Graves 
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INTRODUCTION 
Two of the key enzymes of glycogen metabolism are glycogen phos-
phorylase and glycogen synthase, both of which can exist in inter­
convertible forms. The phosphorylation and dephosphorylation of these two 
enzymes by protein kinases and phosphoprotein phosphatase, respectively, 
are examples of regulation of enzyme activity through enzyme catalyzed 
chemical modification of enzymes (1,2). Because of the presence of phos­
phoprotein phosphatase in many tissues and its action on various phos-
phorylated enzymes, there is considerable interest in the properties of 
this enzyme (3). Metal ions are known to affect this enzyme, but how they 
act is uncertain. Metal ions could affect the reaction by binding to 
2+ 2+ the protein substrate, enzyme or both. Mn and Mg in partially 
purified fractions were activators of the reaction with phosphorylase a 
(4), but in more purified fractions, these metals were found to inhibit 
the reaction (5). Kato et^al- (6) and Merlevede and Riley (7) reported 
2+ 2+ 2+ that metal ions Mg , Mn and Co activated the phosphatase but only 
after pretreatment and inactivation by ATP. Burchell and Cohen (8) 
observed that phosphoprotein phosphatase activity became dependent on 
divalent metal ions during a purification procedure of this enzyme. 
Khatra and Soderling (9) observed that the inactivation of phospho-
2+ protein phosphatase by F~ and ATP can be reversed by Mn . These data 
all suggest that phosphoprotein phosphatase may be a metalloenzyme. 
We examined the effects of several phosphate compounds on phos­
phoprotein phosphatase. The kinetics for trimetaphosphate inactivation 
20 
of phosphatase are analyzed. Both PPi and ATP are physiological metabo­
lites and are potent inhibitors for phosphatase. Possible mechanisms 
for the inactivation of phosphoprotein phosphatase are investigated. 
Although metal ions reactivate the enzyme, the absence of metal ions in 
the purified enzyme and the requirement for a sulfhydryl reagent for 
reactivation suggest that alternate mechanisms to the formation of a 
metalloenzyme should be considered. 
We also report here that the catalytic subunit of phosphoprotein 
phosphatase purified up to the G-75 gel filtration step according to 
procedure of Brandt et al_- (5) can hydrolyze PNPP, but only in the 
2+ presence of Mn . 
A preliminary description of some of this work has been presented 
(10). 
21 
EXPERIMENTAL PROCEDURES 
Preparation of Enzymes 
Phosphorylase ^ was isolated from frozen rabbit skeletal muscle 
(Pel-Freeze Biological Inc.) as described by Fischer and Krebs (11). 
32 P-phosphorylase ^ was prepared from phosphorylase ^ by phosphorylation 
32 
with rabbit muscle phosphorylase kinase and [y- P]ATP (12). Concen­
tration of phosphorylase was determined from the absorbance index of 
13.0 at 280 nm for a 1% protein solution (13). [y-^^P]ATP was prepared 
according to the method of Glynn and Chappell (14). 
Frozen young rabbit livers (Type II, Pel-Freeze Biological Inc.) 
were used for the preparation of phosphoprotein phosphatase catalytic 
subunit. The purification method of Brandt et (5) was followed 
through the G-75 chromatography step. The molecular weight of the 
isolated phosphatase is 35,000 (5). Enzyme that had a specific activity 
of 2300 units/mg and migrated as a single component in SDS gel electro­
phoresis was used. One unit of enzyme is defined as the amount of 
enzyme necessary to convert 0.2 mg phosphorylase a_ to ^ in one minute. 
Imidazole (grade 1) was purchased from Sigma Chemical Co. and was 
recrystallized three times from reagent grade acetone before use. Phos­
phoprotein phosphatase was also prepared from zinc-deficient rat livers 
that were a generous gift from Mr W, J. Bettger (Biochemistry 
Department, University of Missouri-Columbia). Ten zinc-deficient and 
ten control rats were used for the crude preparations of phosphoprotein 
phosphatase up to and including the 75% ammonium sulfate precipitation 
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after the ethanol treatment. All animals were males (65 mg) placed on an 
egg albumin based diet (<1 ppm Zn) for 5 weeks ad libitum. Control 
animals were supplemented to 100 ppm Zn. Animals were killed by 
decapitation; livers were excised, placed on ice, and then stored at 
-20°C. 
Assay of Enzyme Activities 
Unless otherwise indicated, phosphoprotein phosphatase was assayed 
32 by adding 5 yl of the enzyme to 120 yl of P-phosphorylase a^ (3 mg/ml) 
in 50 mM imidazole, 3 mf4 caffeine, 0.5 mM EDTA, and 0.5 mM DTE, pH 7.2. 
After 5 minutes at 30°C, 100 yl was removed and added to 200 yl of ice 
cold 30% trichloroacetic acid and 100 yl of bovine serum albumin 
(20 mg/ml). Aliquots were removed, filtered through glass wool, and 
counted by Cherenkov radiation (15). The rate of phosphate released was 
linear up to 20% conversion of substrate. 
For PNPP as substrate, phosphoprotein phosphatase (5 yl) was added 
to 3.0 ml of PNPP (12 mM) in 50 mM imidazole, 3 mM caffeine, 0.5 mM DTE, 
and 1 mM manganese acetate, pH 7.2. The reaction was carried out in 
plastic, transparent cuvettes because phosphoprotein phosphatase at low 
concentration tended to lose activity in glass vessels. The rate of 
p-nitrophenol released was monitored at 410 nm at 30°C by a Gary Model 
15 recording spectrophotometer. 
The heat stable phosphoprotein phosphatase inhibitor was partially 
purified according to Brandt et (16). Five yl of this partially 
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purified inhibitor inhibited 60% of phosphoprotein phosphatase activity if 
32 
added directly to the assay with P-phosphorylase ^ as substrate. 
Total liver phosphorylase activity was assayed according to Appleman 
(17). A crude extract of liver phosphorylase, 20 yl was added to 
200 yl of substrates containing 32 mTI glucose-l-P, 2% glycogen, 2 mM AMP, 
1 M NagSO^, pH 6.5. After 5 minutes at 30°C, the reaction was stopped by 
addition of 100 yl of 30% trichloroacetic acid. The precipitate was 
removed by centrifugation, and 400 yl of the supernatant fluid was 
removed for inorganic phosphate analysis (18). 
Protein concentration determinations were measured according to 
Bradford (19), using bovine serum albumin as standards. 
Metal Analysis 
Metal analysis was done by inductively coupled plasma atomic emission 
spectroscopy. Ultra pure grade of Tris (Schwarz-Mann Co.) was used. 
Doubly distilled deionized water was used for all buffer and washings. 
All glassware was acid washed, and all plastic containers were rinsed with 
absolute ethanol. Dialysis bags were boiled with 10 mM EDTA. Chelex 
100 (Bio-Rad Lab.) was prewashed with 1 N redistilled HCl and 1 N 
redistilled ammonia before use. The protein sample for analysis was 
dialyzed extensively against 50 mf^ Tris, 0.5 mM DTE, pH 7.5 buffer that 
was treated with Chelex 100. The protein sample was analyzed against a 
blank of buffer used for dialysis. 
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Syntheses and Purification of Phosphate Compounds 
32 P-NagFPOg and sodium trimetaphosphate were synthesized according 
to Ericsson (20). Inorganic phosphate was heated for 5 hours at 500°C to 
give sodium trimetaphosphate. Sodium fluorophosphate was made by quick 
fusion of sodium fluoride and sodium trimetaphosphate. Commercial sodium 
fluorophosphate (K & K Chem., Research organic/inorganic Chem.) or 
synthesized NagFPOg and NagfPOg)^ was purified by a modification of the 
procedure of Higgins and Baldwin (21). A solution of impure phosphate 
compound was passed through a column of AGI x 8, HCOg" form (Bio-Rad.), 
and eluted with a liter gradient of 0 to 2 M NH^HCOg. Various fractions 
can be identified by ascending paper chrotnatogram (22). Whatman #3 paper 
is used with developing solvent consisting of isopropanol, NH^OH, 
trichloroacetic acid and water in the ratio of 75:0.125:5:25. The 
chromatographic spray is made up of 60% perchloric acid, hydrochloric 
acid, ammonium heptamolybdate tetrahydrate, and water in the ratio of 
5:1:1:100. The R^ values for inorganic phosphate, pyrophosphate, 
trimetaphosphate and fluorophosphate are 0.73, 0.42, 0.13, and 0.60, 
respectively. The purified fluorophosphate and trimetaphosphate were 
31 
also checked by P-Fourier transform NMR spectroscopy and the chemical 
shifts corresponded to those reported by Van Wazer et (23). 
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RESULTS 
Inactivation by Phosphate Compounds 
The inactivation of crude phosphoprotein phosphatase by commercial 
sodium fluorophosphate and not by phosphite was reported previously from 
our laboratory (24). From kinetic studies and inorganic phosphate 
protection, data were consistent with an irreversible covalent modifi­
cation of the active site of phosphoprotein phosphatase by fluoro­
phosphate. Similar experiments were repeated with the highly purified 
catalytic subunit of phosphoprotein phosphatase, with commercial sodium 
fluorophosphate, with similar results. To further investigate this 
32 inactivation mechanism, P-NagFPOg was synthesized according to 
Ericsson (20). Upon purification of the synthesized sodium fluoro­
phosphate, the isolated sodium fluorophosphate at 50 mM caused only a 
slight inactivation of the catalytic subunit of phosphoprotein phos­
phatase. No incorporation of label into the enzyme was detected. Also 
little inactivation was seen with commercial sodium fluorophosphate 
that was purified (Experimental Procedures). It was found that sodium 
fluorophosphate obtained commercially contained 5-20% impurities. Upon 
further investigation of the content of the impurities, PPi and trimeta­
phosphate were found to be the major contaminants. Therefore, the effects 
of these compounds were studied further. 
Figure I-l indicates that a time dependent inactivation of phos­
phoprotein phosphatase occurs in a presence of trimetaphosphate. The 
enzyme was preincubated with trimetaphosphate, and then dilutions were 
made at various times to lower the concentration of trimetaphosphate in 
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the assay to a level where no inhibition occurred. Figure I-l also shows 
that the inactivation of phosphatase by trimetaphosphate can be protected 
by inorganic phosphate, a competitive inhibitor of phosphorylase a^ 
dephosphorylation. These observations suggest that the inactivation of 
the phosphatase by trimetaphosphate is active site directed and could be 
due to an irreversible covalent modification. 
A kinetic model for irreversible covalent inhibition has been 
proposed by Kitz and Wilson (25): 
Kj kg 
E + I ^ E • I -> E-I 
This model predicts a binding step preliminary to covalent modification, 
and consequently, the inactivation process should show saturation 
kinetics. Kj and kg can be determined from the rates of inactivation at 
different inhibitor concentrations, according to the equation; 
1 K, 1 
= —±— + 
"^app "^2^ kg 
Figure 1-2 shows that the inhibition conforms to the rate law for 
saturation kinetics with respect to trimetaphosphate and that the values 
of K j  and kg are 4.6 x 10~^ M and 0.29 min"\ respectively. 
ATP was reported by Kato et (6) and PPi by Li and Hsiao (26) 
to be inhibitors for phosphoprotein phosphatase. The inactivation of 
phosphoprotein phosphatase by these two physiological metabolites was 
investigated in more detail to reveal possible mechanism of inactivation. 
Figure I-3a, 3b shows that the inactivation of phosphoprotein phosphatase 
by PPi or ATP is time dependent, similar to that of trimetaphosphate. 
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However, the inactivation kinetics consist of an initial fast phase and 
a slower second phase. The inactivation effect by PPi or ATP on the 
phosphatase is more pronounced if EDTA is present in the preincubation 
mixture. Phosphoprotein phosphatase loses more than 95% of its 
activity after preincubating at 30°C for 10 minutes with 0.5 mM EDTA 
and 0.5 mM PPi or 4 mM ATP and 0.5 mM EDTA. EDTA (0.5 mM) alone did not 
inactivate phosphoprotein phosphatase. The inactivation by PPi or ATP 
can be protected by inorganic phosphate, suggesting that it involves the 
active site. The data showing the biphasic characteristic of PPi or ATP 
inactivation of phosphatase are reproducible. However, because of the 
error involved in the initial phase data points, no dissociation 
constants of enzyme-inhibitor complex or rate constants are calculated. 
Alone, inorganic phosphate, fluorophosphate, and phosphite at 
50 mM have little effect on phosphatase inactivation (data not shown). 
The three compounds that do inactivate have more than one phosphorous 
atom, and one of the possible mechanisms of inactivation by PPi, ATP, or 
trimetaphosphate could be a nucleophilic attack by the active site of the 
phosphoprotein phosphatase on these compounds. Stable analogs of PPi and 
ATP were tried. Methylene diphosphonate was used in place of PPi, and 
adenylyl(B,Y-methylene)-diphosphonate was used in place of ATP. Figure 
1-4 shows that both these analogs inactivate the enzyme. The kinetics 
can be described by a first order reaction similar to that of trimeta­
phosphate, though the analogs are less potent than PPi or ATP. These 
results suggest that inactivation does not involve a hydrolytic mechanism. 
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Reactivation of the Inactivated Phosphatase 
Different methods of reactivating the inactivated phosphatase 
induced by PPi or ATP were tried in order to elucidate the mechanism of 
inactivation. Two divalent cations, manganese and cobalt, were success-
2+ ful in reactivating inactivated phosphatase. Experiments with Mn are 
illustrated in Figures 1-5 and 1-6. In Figure 1-5, phosphatase pre-
incubated with PPi was assayed with different concentrations of manganese 
32 in the assay together with P-phosphorylase a_. The data showed that 
2+ 
reactivation was dependent on manganese concentration. One mM Mn or 
0.3 mM Co^* would give full reactivation of the PPi or ATP inhibited 
2+ 2+ phosphatase. To determine whether the influence of Mn or Co was on 
the phosphatase and not on the substrate, phosphorylase a_, phospho-
protein phosphatase was preincubated with 0.5 mM PPi and 0.5 mM EDTA, 
at 30°C for 10 minutes, and the mixture applied to a Sephadex G-50 
column. Fractions were assayed for phosphoprotein phosphatase activity 
2+ before and after the addition of 1 mM Mn to the fractions. No 
2+ 
additional Mn was added to the assay mixture (Figure 1-6). There was 
2+ 
six-fold activation when Mn was added to fractions containing 
phosphatase. 
Other metals such as Mg^* (0.5 mM - 3.0 mM), Zn^* (0.3 mM - 1.0 mM), 
and 0.5 mM of Cu^*, Fe^*, Ca^*, Ni^^, Cd^*, Cr^* showed no reactivation 
of phosphatase inactivated by PPi or ATP. Other cationic compounds 
which were tried included 0.5 mM to 4.0 mM lysine, arginine, spermine, 
ethylenediamine, and arginine methyl ester. No reactivation was seen by 
these compounds. The reactivation experiments strongly suggest that the 
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phosphoprotein phosphatase is a metalloenzyme. There are two possible 
explanations for the inhibition of PPi or ATP. PPi or ATP can act as 
a chelating agent and remove a metal from the native phosphatase 
important for catalysis. On the other hand, PPi or ATP might not 
remove a metal ion but might chelate a metal ion in the active site. 
32 The latter hypothesis of direct binding can be tested, [y- P]ATP was 
used as a possible labeling reagent for phosphoprotein phosphatase. 
0.2 nmole of phosphoprotein phosphatase was preincubated with 2.5 mM 
[Y-^^P]ATP and 0.5 mM EDTA at 30°C for 10 minutes. (Specific activity 
32 9 
of [y- P]ATP was 2 x 10 cpm/vimole). Then the mixture was passed 
through a Sephadex 6-50 column. Assuming one mole of ATP bound per 
mole of phosphatase, a total of 4 x 10^ cpm was expected to be 
incorporated into phosphoprotein phosphatase. Less than 1% of that 
expected, however, comigrated with phosphatase activity assayed before 
2+ 
and after Mn was added to the fractions (Figure 1-7). 
Metal Analysis 
An attempt was made to find out by metal analysis if phospho­
protein phosphatase is a metalloenzyme. A trial run using alcohol 
dehydrogenase (Sigma Chem.) was done. Sample with the same protein 
concentration as that of the phosphatase was submitted for analysis, 
and stoichiometric amount of zinc was found (data not shown). After 
extensive dialysis, 2.3 nmoles/ml of phosphoprotein phosphatase was 
used for analysis (Experimental Procedures). At this stage, 70% of the 
enzyme activity was retained. The analysis data (Table I-l) did not 
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show any significant amount of any of the ten metals (Ca, Cd, Co, Cu, Fe, 
Mg, Mn, Ni, Sn, Zn). 
Zinc-deficient Rats 
Even though the metal analysis data do not show any significant 
2+ 
amount of any metal, further studies for a possible involvement of Zn 
were done since E. coli alkaline phosphatase and mammalian alkaline 
phosphatase (27,28) are known to be zinc metalloenzymes. We were able 
to obtain livers from zinc-deficient rats to test whether the level of 
2+ Zn had any appreciable effect on phosphoprotein phosphatase. Phospho­
protein phosphatase and total phosphorylase activities were assayed 
before and after ethanol treatment of the crude extract (Table I-II). 
There were essentially no differences between zinc-deficient rats and 
the control rats in phosphatase activity and phosphorylase activity. 
Since no NaF had been added in the crude extract, all the phosphorylase 
was in the ^ form after the first 70% ammonium sulfate treatment (29). 
Sulfhydryl Reagent Requirement 
Since metal analysis data did not show any significant amount of 
any metal in phosphoprotein phosphatase, other possible mechanisms by 
2+ 2+ 
which Mn or Co could reactivate the inactivated phosphoprotein 
2+ phosphatase have been investigated. We observed that Mn in the 
absence of any sulfhydryl reagent could not reactivate the PPi or ATP 
inactivated phosphoprotein phosphatase. As shown in Table I-III, there 
2+ is a difference in the effectiveness of activation by Mn with the 
different sulfhydryl compounds tested. Dithioerythritol was the best, 
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followed by g-mercaptoethanol and cysteine. Reduced glutathione and 
oxidized dithiothreitol were without effect. 
With 20 mM DTE in the preincubation mixture containing phospho-
protein phosphatase, 4 mM ATP and 0.5 mM EDTA comparing with no DTE 
present, the initial fast phase of inactivation of the phosphatase by 
the ATP was slowed down three-fold. There was no appreciable effect on 
the second slower phase (data not shown). 
Small Molecular Weight Substrate Specificity 
It is known that phosphoprotein phosphatase has different metal 
requirements with different phosphoprotein substrates. With phosphoryl-
ase ^ as substrate, it is inhibited by divalent metals (5,30). With 
glycogen synthase D, phosphorylase kinase, and casein as substrates, 
it is activated by divalent metals (31,32). Small molecular weight 
phosphate esters were not found to be substrates (4,32). To test if 
the Co^ or Mn^ reactivated phosphatase has different metal requirements 
or properties from the native phosphatase, small molecular weight 
phosphate esters as substrates were investigated. In the presence of 
different divalent metals, native phosphatase was tested for its ability 
to hydrolyse any of these small phosphate esters. We found that 
p-nitrophenol phosphate to our surprise is a good substrate for 
phosphoprotein phosphatase, but only in the presence of manganese. PNPP 
2+ 2+ 2+ 2+ 2+ hydrolysis in the presence of Ca , K , Mg , Co , or Zn also were 
2+ 2+ 2+ tried. Mg and Zn , at the same concentration as Mn , showed less 
2+ 
than 57o the rate of hydrolysis of PNPP as Mn (data not shown). 
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2+ Other small molecular weight substrates had been tried with 1 mM Mn 
but showed no detectable hydrolysis by the phosphoprotein phosphatase. 
These include 20 mM glucose-1-phosphate, glucose-6-phosphate, 
fructose-6-phosphate, serine phosphate, g-glycerol phosphate, 2,3-
diphosphate glyceraldehyde, and phosphoethanolamine. The of PNPP 
for substrate is 1.1 mM (Figure 1-8), and is 15.2 ymole/min/mg, 
while the of phosphorylase a_ for substrate is 4 uM (5,32). The 
turnover rate of PNPP is 6.5 times faster than phosphorylase ^ as in 
Table I-II. 
Experiments were then carried out to show whether the phosphatase 
activities toward phosphorylase ^ and PNPP come from one enzyme or 
different enzymes. Data in Table I-II also show that the hydrolysis of 
PNPP is not activated by the ethanol treatment, whereas the dephos-
phorylation of phosphorylase ^ is. Inorganic phosphate is a competitive 
inhibitor for PNPP with of 0.46 mM (data not shown). Phosphorylase à 
is not an inhibitor for PNPP. In Table I-IV, results of heat inactivation 
are shown. The activity towards PNPP is more heat labile than the 
activity towards phosphorylase It is known that phosphoprotein 
phosphatase is inhibited by NaF with phosphoproteins as substrates (29). 
However, 50 mM NaF has no effect on PNPP hydrolysis by phosphoprotein 
phosphatase (data not shown). The heat stable phosphoprotein phospha­
tase inhibitor (16) was partially purified. It was shown to inhibit 
phosphoprotein phosphatase activity with phosphorylase ^ as substrate 
(Experimental Procedures). This protein inhibitor, however, did not 
inhibit PNPP hydrolysis at all. Therefore, if this PNPP hydrolysis 
33 
is due to a contaminating manganese specific phosphatase in the phos-
phoprotein phosphatase, the enzyme is copurified up to and including 
the G-75 chromatography of the procedure by Brandt et £L- (5). 
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DISCUSSION 
The inactivation of phosphoprotein phosphatase by various phosphate 
compounds has been reported (26). In this work, effects of some of 
these compounds on phosphatase itself were examined in more detail. 
Trimetaphosphate is found to modify phosphoprotein phosphatase. 
The inactivation by trimetaphosphate on phosphatase is time and concen­
tration dependent and cannot be reversed by removal of trimetaphosphate 
by dilution or gel filtration. Both PPi and ATP inactivate phospho­
protein phosphatase. The inactivation is protected by inorganic 
phosphate, suggesting that the inactivation by PPi or ATP is active site 
directed. Phosphate compounds such as inorganic phosphate, fluoro-
phosphate or phosphite are inhibitors but do not inactivate the 
phosphatase (26). Trimetaphosphate, PPi and ATP all inactivate phos­
phatase, and they have the ability to phosphorylate or adenylylate 
phosphatase. But both analogs of PPi or ATP, methylene diphosphonate 
and AMPPCP, are inhibitors for this phosphoprotein phosphatase. Thus, 
inactivation by these phosphate compounds is probably not by hydrolysis 
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of these compounds. The inability of [y- P]ATP to label the phosphatase 
indicates the possibility that some important element is being removed 
or changed in the active site. 
The fact that the PPi or ATP inactivated phosphoprotein phosphatase 
2+ 2+ 
can be reactivated by Mn or Co strongly suggests that a metal may be 
involved in the active site. No other cationic compounds have been 
found to work. Also, the specificity of divalent metals indicates that 
the reactivation is not just due to positive charges. Kato et al. 
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(6) and Merlevede and Riley (7) had reported the inhibition of partially 
2+ purified phosphoprotein phosphatase by ATP and the reactivation by Mg , 
2+ 2+ Mn and Co . Burchell and Cohen (8) recently showed that phosphorylase 
phosphatase may be a manganese metalloenzyme. They showed that they 
could activate some fractions of low activity phosphorylase phosphatase 
2+ 
specifically by Mn . Similar observations have also been reported by 
Kato and Bishop (4). 
That PPi-EDTA or ATP-EDTA is more inhibitory to the phosphatase 
can be explained by EDTA removing any metals in the buffers that can 
slow down the PPi or ATP inhibition. It can also be explained that PPi 
or ATP serves to "open up" the active site of phosphatase so that EDTA 
can chelate away the metal in the active site. 
Therefore, an attempt was made to find out if the purified catalytic 
subunit of phosphoprotein phosphatase had any tightly bound metal. The 
metal analysis failed to show any significant amount of the ten metals 
checked, especially manganese and cobalt. The zinc-deficient rat liver 
phosphoprotein phosphatase activity eliminates the possibility of zinc 
in the active site. Thus, the effect of PPi or ATP on phosphoprotein 
phosphatase may not be as simple as just the removal of a metal from 
the active site. The metal may be catalyzing some reaction that can 
reactivate the phosphatase inactivated by these phosphate compounds. 
There are preliminary data that indicate this possibility. The PPi-
inactivated phosphatase can only be reactivated by the presence of both 
2+ Mn and the reduced form of a sulfhydryl reagent. Either one alone 
2+ 2+ 2+ 
cannot reactivate the phosphatase. Mn , Co , and Fe are the three 
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metals among all the metals we have tried that can exist at a next higher 
oxidation state by a loss of one equivalent of electron, namely as Mn^*, 
3+ 3+ 3+ 3+ Co 5 and Fe . However, the oxidation potentials of Mn and Co are 
1.5 v and 1.8 v, respectively, which are much higher than that of Fe^* 
3+ ?+ 
of 0.77 v (33). Mn and Mn can exist in equilibrium even though the 
2+ 
equilibrium very strongly favors the Mn state (34). So in a solution 
2+ 3+ 
of Mn salt, there is a possibility of a trace amount of Mn . It has 
been known that sulfhydryl groups are catalytically oxidized in the 
3+ presence of some transition metals (35). Mn is a very strong 
oxidizing agent that can facilitate reaction such as illustrated in the 
equation that follows. The very reactive free radical formed might 
further catalyze some reaction that is otherwise impossible (34) such 
as a mixed disulfide exchange with the protein. 
RS" + Mn3+ y RS* + Mn2+ 
So PPi or ATP might cause a chemical change of the phosphatase, and 
inactivate the enzyme. This chemical change can only be reversed by a 
reaction involving manganese (or cobalt) and a sulfhydryl reagent. As 
shown in Table I-III, there is a preference of sulfhydryl reagents used. 
DTE by far has the lowest reduction potential of all sulfhydryl reagents 
tried. The reduction potentials of DTE, cysteine, and glutathione are 
-0.366 V, -0.23 V and -0.24 v, respectively (36). So DTE can reduce a 
disulfide better, which may be a possible reason for a preference of DTE 
in this instance. Glutathione, even though it has the same reduction 
potential as cysteine, cannot reactivate the phosphatase, probably 
because of its larger molecule size. Gratecos e^ al_. (37) reported the 
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inactivation of phosphatase by 5,5-dithio-bis-(2-nitrobenzoic acid) and 
partial reversal by DTE. This suggests that there is some sulfhydryl 
group in the phosphatase important for activity. 
As this manuscript was being prepared, Hsiao et al_. (38) reported 
that the catalytic subunit of phosphoprotein phosphatase can be inacti­
vated by pyrophosphate and ATP, and can be reactivated afterwards only 
2+ 2+ ?+ 2+ 
with Co or Mn . The Co or Mn reconstituted phosphatase is 
different in sensitivity towards pyrophosphate or ATP as compared with 
the native phosphatase. This suggested that even if the phosphoprotein 
2+ phosphatase is a metalloenzyme, the native metal is probably not Co 
2+ 
or Mn . Shimazu et (39) also recently reported that they found a 
natural inhibitor, oxidized glutathione, in rabit livers for phospho­
protein phosphatase. The inactivated phosphatase can be partially 
reactivated by reduced glutathione or mercaptoethanol, but can be fully 
2+ ?+ 
reactivated by Mn and reduced glutathione. Mn alone is without 
effect. Our data are slightly different in that sulfhydryl reagents 
alone cannot reactivate the PPi or ATP inactivated phosphatase. Also 
2+ from Table I-III, reduced glutathione and Mn together cannot reactivate 
the inactivated phosphatase. However, Shimazu e^ aj_. (39) were working 
with a phosphatase of molecular weight of 48,000, different from ours. 
So the phosphatase they were working with have slightly different 
properties. In general, their data reinforce ours in that we consider 
2+ 2+ the Mn or Co reactivation of phosphatase as a possible facilitated 
reduction of an important sulfhydryl group in the phosphatase, rather 
than just the replacement of a metal removed by PPi or ATP, 
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The hydrolysis of p-nitrophenyl phosphate in the presence of 1 mM 
2+ Mn by phosphoprotein phosphatase reported here has not been reported 
previously as far as we know (4,29,31,32,40,41). No previous workers 
had observed any hydrolysis of small molecular weight phosphate esters 
by phosphoprotein phosphatase. They had assayed these phosphate 
2+ 
esters either in the absence of metal or in the presence of Mg . Kato 
and Bishop (4) had reported the failure of hydrolysis of small molecular 
2+ 
weight phosphate esters in the presence of Mn by phosphoprotein 
phosphatase. However, PNPP was not included in the list of phosphate 
esters reported. A PNPP-phosphatase activity was shown to exist in 
2+ 
rabbit liver in the presence of Mg (42). The phosphoprotein 
phosphatase was purified according to Brandt et (5) up to and 
including the G-75 gel filtration with a specific activity of 2300 
units/mg, and was shown to have little activity toward PNPP in the 
2+ presence of Mg . The heat stable phosphoprotein phosphatase inhibitor 
does not inhibit PNPP hydrolysis. The 80% ethanol treatment in the 
purification of the phosphoprotein phosphatase does not activate the 
PNPP hydrolysis. These suggest that the PNPP hydrolysis has different 
characteristics. It could be due to properties of one enzyme being 
expressed differently toward two substrates or due to a contaminating 
phosphatase. Further work has to be done to clarify this. 
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Table I-I 
Metal analysis of phosphoprotein phosphatase by inductively coupled plasma atomic 
emission spectroscopy. 
2.3 nmole/ml of phosphatase was dialyzed extensively against 50 mM Tris, 0.5 DTE pH 7.5 
(experimental procedures). A blank of buffer was used. 
Detection Phosphatase expected 
limit sample value 
(ppm) (ppm)a (ppm)° 
Ca 0.003 0,015 0.092 
Cd 0.0002 0.001 0.258 
Co 0.0002 N.D.c 0.136 
Cu 0.0001 0.002 0.145 
Fe 0.002 0.030 0.129 
Mg 0.0001 0.016 0.055 
Mn 0.00003 0.001 0.127 
Ni 0.002 N.D. 0.136 
Sn 0.017 N.D. 0.274 
Zn 0.001 0.016 0.150 
^Values subtracted from the buffer bank. 
'^Assuming 1 mole of metal per mole of enzyme. 
^N.D. - Non-determinable, below detection limit. 
Table I-II 
Phosphoprotein phosphatase and phosphorylase activity of zinc-deficient rat livers. 
10 zinc-deficient rat livers (19 gm) and 10 normal rat livers (41 gm) were used. 
(Experimental procedures) 
Normal Rat Livers As Controls Zinc-deficient Rat Livers 
Phosphatase 
activity 
(units/mg) 
Phosphorylase 
activity 
(ymole/min/g) 
PMPpa 
(nmoles/min/mg) 
Phosphatase 
activity 
(units/mg) 
Phosphorylase 
activity 
(ymole/min/g) 
70% (NH^)2S04 0.12 58 33 0,26 71 
precipitation 
80% ethanol 10.0 B (M 65 12.3 w « w 
treatment 
^Phosphoprotein phosphatase activity assayed with p-nitrophenyl phosphate as substrate. 
This column is explained in the last section of Results. 
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Table I-III 
Reactivation of PPi-inactivated phosphoprotein phosphatase in the 
presence of manganous ion and different sulfhydryl reagents. 
[Sulfhydryl reagents] [Mn^*] % of reactivation® 
5 mM DTE (reduced) 
1 mM DTE (reduced) 
15 mî4 mercaptoethanol 
5 mM cysteine 
6 mM glutathione (reduced) 
5 mM glutathione (oxidized) 
0 mM DTE^ (reduced) 
0 mM mercaptoethanol 
5 titf-l oxidized dithiothreitol 
5 100 
5 mM 94 
5 mM 83 
5 mM 67 
5 mM 0 
5 mM 0 
5 mM 0 
5 mT-l 0 
5 mM 0 
Phosphoprotein phosphatase was preincubated with 1.0 mM PPi at 
30°C for 10 min. At the end of 10 min, there was no detectable 
activity left, as assayed in the absence of Mn^"*" and sulfhydryl 
reagents. % of reactivation was observed when Mn^"*" and/or sulfhydryl 
reagent were included in the assay with phosphorylase a_as substrate. 
Phosphorylase used in this experiment was recrystallized 4 times in 
50 mM imidazole buffer in the absence of any sulfhydryl reagent. 
45 
Table I-IV 
Heat denaturation of phosphoprotein phosphatase. 
Time of % of phosphatase 
Substrate preincubation activity remained 
at 37°C (min) 
PNPP 5 89.3 
PNPP 13 55.7 
Phosphorylase a^ 5 91.9 
Phosphorylase ^ 13 81.9 
^Phosphoprotein phosphatase was preincubated at 37°C 
before an aliquot was taken and assayed at 30°C. 
Figure I-l. The effect of preincubating phosphoprotein phosphatase with sodium 
trimetaphosphate. Phosphoprotein phosphatase was preincubated with 
( A )  0.5 mM NagfPOgjg; ( # ) 5 mM NagtPOg)^; a n d  (  O  ) 5 mM Na^fPOg)], 
12.5 mM Pi at 30°C. At various times, an aliquot was taken out and 
diluted twenty-fold with 50 mM Imidazole, 0.5 mM DTE^ pH 7.2. Then 
5 yl was taken, diluted and assayed. The assay mixture contained 
3? P-phosphorylase ^ (3 mg/ml) in 50 mM Imidazole, 3 mM Caffeine, 
0.5 mM EDTA, 0.5 mM DTE^, pH 7.2. After 5 minutes at 30°C, 100 yl 
was removed and added to 200 yl of ice cold 30% trichloroacetic acid, 
and 100 yl of bovine serum albumin (20 mg/ml). Aliquote were 
counted after filtering through glasswool by Cerenkov radiation (15) 
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Figure 1-2. Double reciprocal plot for the inactivation of 
phosphorylase phosphatase in the presence of 
trimetaphosphate. Kapp values were determined 
from the slope of log (% activity) y^. time plots 
at the indicated concentrations of trimetaphosphate. 
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Figure 1-3. The effect of preincubating phosphoprotein 
phosphatase with PPi and ATP. Phosphoprotein 
phosphatase was preincubated at 30°C with: 3a; 
(•) 0.5 EDTA; (O) 0.5 mM PPi; (#) 0.5 mM PPi, 
0.5 mM EDTA: 3b; (•) 0.5 mM EDTA; (O) 4.0 mM 
ATP; (•) 4.0 mM ATP, 0.5 mM EDTA, Then at 
various times, an aliquot was taken and the 
remaining phosphatase activity was assayed as in 
Figure 1-1. 
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Figure 1-3 (continued) 
Figure 1-4. Effect of methylene diphosphonate and AMPPCP^ on phosphoprotein 
phosphatase. (0) 5 mM methylene diphosphonate and (Q) 2 mM 
AMPPCP^ were preincubated with phosphoprotein phosphatase at 
30°C. At various times, an aliquot was taken and the 
remaining phosphatase activity was assayed as in Figure I-l, 
100 
90 
80 
70 
60 
c: 50 
ai 
"* 40 
S 30 
20 
10 0 4 6 
Preincubation 
O 
en 4^ 
I I I 
8 10 12 14 
Time (min) 
Figure 1-5. The reactivation of PPi-inactivated phosphoprotein 
2+ phosphatase by Mn in the assay mixture. Phospho­
protein phosphatase was preincubated with 0.5 mM PPi 
at 30°C. At various times, an aliquot was taken, 
diluted and assayed with (A) no addition, 
( O )  0 . 1  m M  M n ^ * ,  ( # )  0 . 6  m M  M n ^ * .  T h e  r e s t  o f  
32 the assay mixture contained P-phosphorylase a^ 
(3 mg/ml) in 50 mM Imidazole, 3 mM Caffeine, 0.5 mM 
DTe\ pH 7.2. The assay procedure was the same as 
Figure I-l. 
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Figure 1-6. The reactivation of PPi-inactivated phosphoprotein 
2+ phosphatase by Mn . Phosphoprotein phosphatase was 
preincubated with 0.5 mM PPi and 0.5 mM EDTA for 
10 minutes at 30°C. Then the mixture was passed 
through a Sephadex G-50 column (50 cm x 1 cm). The 
column wall was coated with 1% solution of dimethyl-
dichlorosilane in benzene to prevent excessive 
adhesion of phosphoprotein phosphatase. PPi and 
phosphoprotein phosphatase were separated on the 
column. ( O), PPi was detected by the method of 
Fiske and Subbarow (60) after boiling with 1 N 
HgSO^ for 10 minutes. Fractions with phosphoprotein 
phosphatase were assayed, (A), before and, (# ), 
?+ 
after addition of 1 mM Mn . The assay procedure 
was the same as Figure 1-5. 
58 
With Mn 
Without 
Mn PPi 
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Figure 1-7. Preincubation of phosphoprotein phosphatase with 
32 [y- P] ATP. Experimental procedure was similar to 
that of Figure 1-5. 0.2 nmole of phosphoprotein 
32 
was preincubated with 2.5 mM [y- ] ATP and 0.5 mM 
EDTA at 30°C for 10 minutes. (Specific activity of 
32 G [y- P] ATP was 2 x 10 cpm/ymole.) The mixture was 
then passed through a Sephadex G-50 column (50 cm x 
1 cm). An aliquot of each fraction was taken and 
counted for radioactivity, ( A ). Fractions with 
phosphoprotein phosphatase were located by assaying, 
( # ) before and, ((j), after addition of 1 mM 
60 
ATP 
With Mn 
Without Mn 
Fraction No. (1.0 ml each) 
Figure 1-8. Double reciprocal plot for phosphoprotein phosphatase 
activity toward p-nitrophenol phosphate hydrolysis in 
2+ the presence of Mn . Phosphoprotein phosphatase (5 JJI) 
was added to 3.0 ml of PNPP^ in 50 mM Imidazone, 3 mM 
Caffeine, 0.5 mM DTE, 1 mM Mn^*, pH 7.2. The reaction 
was carried out in plastic cuvettes. The rate of 
p-nitrophenol released was monitored at 410 nm at 30°C 
by a Gary Model 15 recording spectrometer. 
1/V (n mole/min) 
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SECTION II: A ROLE FOR PYRIDOXAL PHOSPHATE IN THE CONTROL OF 
DEPHOSPHORYLATION OF PHOSPHORYLASE a 
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INTRODUCTION 
An a-glucan phosphorylases contain firmly bound pyridoxal phosphate 
and require this coenzyme for catalytic activity (1,2,3). The exact role 
of pyridoxal phosphate in catalysis is not known, but clearly it does not 
function as it does in other vitamin Bg-containing enzymes (3,4). Amino 
acid sequence analysis of pyridoxal phosphate binding sites of 
phosphorylases from rabbit, potato, yeast, and E. coli (5,6,7,8) shows 
that this region of the protein is highly conserved, a fact that is 
consistent with an involvement of the coenzyme in an important function. 
One approach taken to evaluate the role of the coenzyme is to study 
the properties of the apoenzyme and phosphorylases reconstituted with 
various pyridoxal phosphate analogs. Physical studies have shown that 
the structures of apophosphorylases ib and ^ are different from their 
holoenzymes (9,10,11), and although major structural changes occur upon 
the binding of various pyridoxal phosphate analogs (3,10), differences 
still exist in the conformation of these reconstituted phosphorylases 
from the native enzyme (11). Graves et al_. (12,13) used enzymes to 
probe conformational differences in apophosphorylase, pyridoxal-
reconstituted phosphorylase, and native phosphorylase and concluded that 
the coenzyme affects enzymatic reactions involving the amino terminal 
domain, e^.^,., phosphorylation and dephosphorylation and limited 
proteolysis by trypsin. Results from measurements of catalytic activity 
of various reconstituted phosphorylases suggest that the phosphoryl group 
of the coenzyme is particularly important, and suggestions have been made 
that it might participate in a proton shuttle (11,14,15). 
Recent studies using x-ray crystallography (15,17) and pyridoxal 
reconstituted phosphorylase (18) show that the coenzyme is in close 
proximity to the binding site for the substrate, glucose 1-phosphate. 
X-ray crystallography has also shown that a nucleoside binding site is 
adjacent to the glucose or glucose 1-phosphate site (20) and is some 
30 Â away from the AMP binding site, which in turn is near the phos-
phorylatable serine (19). Because our earlier results (12,13) 
suggested that the influence of effectors on dephosphorylation of 
phosphorylase a_ depended on the coenzyme, and because information is 
now available about effector binding sites in phosphorylase, we have 
made a comprehensive study of the action of certain effectors. Our 
results with phosphorylases reconstituted with different pyridoxal 
phosphate analogs suggest that the phosphoryl group of the coenzyme 
is important for effects of glucose and caffeine on phosphorylase a_ 
structure and for dephosphorylation. Effects of AMP on 
dephosphorylation, however, are seen in the absence of coenzyme. 
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MATERIALS AND METHODS 
Rabbit muscle phosphorylase ^ was prepared according to Fischer 
and Krebs (21). Phosphorylase ^ was made by the procedure of Krebs 
(22) using [y-^^P]ATP (23) with phosphorylase kinase (24). Phospho-
protein phosphatase was purified according to Brandt et al_. (25). 
The final step of purification, the hexadiamine chromatography, was 
not included. 
Apophosphorylase ^ was prepared from phosphorylase a_ by a modifi­
cation of Shaltiel's method (10). The major changes were the inclusion 
of 10% 1,2-dimethoxyethane in the deforming buffer and a higher 
incubation temperature (about 22°C). Complete details of the modifi­
cation will be published elsewhere. The extent of resolution was 
tested by preincubating the apophosphorylase ^ with or without a 
5-fold excess pyridoxal phosphate at 30°C for 15 minutes. The 
resulting phosphorylase activity was measured by the method of 
Illingworth and Cori (26). The apophosphorylase a thus obtained was 
better than 99.5% resolved and could be reconstituted with pyridoxal 
phosphate to at least 60 lU/mg in the presence of 1 mM AMP, Apophos­
phorylase ^ reconstituted with pyridoxal phosphate had the same 
properties as native phosphorylase a^, as determined by sedimentation 
characteristics, enzymatic activities, and as a substrate for 
phosphoprotein phosphatase, 
a-Methylpyridoxal phosphate [1-methyl-1-(4-formyl-3-hydroxy-2-
methyl-5-pyridyl)methyl-phosphoric acid] was a generous gift from 
Dr. Walter Korytnyk, Roswell Park Memorial Institute, Buffalo, New York. 
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The phosphoethyl analog of pyridoxal phosphate [2-(4-formyl-3-hydroxy-
2-methyl-5-pyridyl)ethyl phosphonic acid] and the phosphonoethenyl analog 
[2-(4-formyl-3-hydroxy-2-raethyl-5-pyridyl)ethenyl phosphonic acid] were 
prepared by Dr. Retsu Miura according to Hullar (27). 5-Deoxypyridoxal 
and the carboxyethenyl analog of pyridoxal phosphate [2-(4-formyl-3' 
hydroxy-2-methyl-5-pyridyl)ethenylcarboxylic acid] were synthesized by 
the methods of Iwata, and Miura and Metzler, respectively (28,29), The 
phosphonomethyl analog of pyridoxal phosphate [l-(4-formyl-3-hydroxy-2-
methyl-5-pyridyl)methyl phosphonic acid] and pyridoxal phosphate methyl 
ester [methyl l-(4-formyl-3-hydroxy-2-methyl-5-pyridyl)methyl 
phosphate] were made by C. N. Han (30). Phosphorylase ^ reconstituted 
with pyridoxal phosphate analogs was prepared by incubating 3-4 mg/ml 
apophosphorylase ^ with a 25-fold excess of analogs in 40 mM g-glycerol 
phosphate, 30 mM mercaptoethanol, pH 6.8. After 30 minutes at 30°C, 
the reconstituted enzyme was precipitated by adding an equal volume of 
neutralized saturated ammonium sulfate solution. Then, the 
reconstituted enzyme was dialyzed extensively against 50 mM Tris, 30 mM 
mercaptoethanol, pH 7.5. Pyridoxal phosphate reconstituted phos­
phorylase ^ was prepared with only 5-fold excess of pyridoxal phosphate 
over the apophosphorylase a^. The extent of reconstitution by all the 
analogs was tested by assaying activity with or without pyridoxal 
phosphate and was found to be 100%. 
Concentrations of phosphorylase were determined either by radio­
activity or spectrophotometrically at 280 nm assuming an absorbance of 
13.0 for a 1% protein solution (31), 
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32 The rate of dephosphorylation of [ P]phosphorylase ^ or pyridoxal 
32 phosphate analog reconstituted [ P]phosphorylase a_was measured by the 
O p  
same procedure used by Parrish and Graves (32). P-Inorganic phosphate 
released was counted by Cerenkov radiation (33). 
Sedimentation velocity experiments were done with a Beckman Spinco 
Model E ultracentrifuge. The movement of protein boundaries was 
followed by schlieren optics. The schlieren patterns were analyzed with 
a microcomparator. Sgg ^ values were calculated by a linear regression 
program of an HP-25 calculator. 
1,2-Dimethoxyethane was obtained from Eastman Kodak, Grade I 
imidazole from Sigma was recrystallized three times from reagent grade 
acetone before use. Shellfish glycogen from Sigma was further purified 
according to Anderson and Graves (34). 
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RESULTS 
In 1951, Sutherland (35) found that caffeine and AMP affected the 
dephosphorylation of phosphorylase ^ by phosphoprotein phosphatase. 
Using an alternative substrate, Nolan et aj_. found that the effects of 
caffeine and AMP were due to their interactions with the substrate, and 
not with the phosphatase (36), To determine the role of pyridoxal 
phosphate in the influence of AMP and caffeine on enzymatic dephos­
phorylation, effects of these modifiers were compared on native 
phosphorylase a^, apophosphorylase and phosphorylase ^ reconstituted 
with pyridoxal. 
As shown in Figure Il-la, the rate of dephosphorylation of native 
phosphorylase a_ by phosphoprotein phosphatase is increased 2,2-fold by 
3 mM caffeine and is inhibited 95% with 3 mM AMP, Three different 
concentrations (0.2 mM, 1 mf4, 3 mM) of caffeine and AMP were tried. 
Only the data for effectors at 3 mM are shown in Figure II'-l because 
this concentration gave the maximum effect. Three different protein 
substrate concentrations (3 mg/ml, 1 mg/ml, 0.2 mg/ml) were also tried 
because the quaternary structure of phosphorylase ^ changes with enzyme 
concentration, i..e^., dissociation of a tetramer to a dimer occurs upon 
dilution (37), The percentage change in rate of dephosphorylation 
caused by the effectors, however, was found independent of protein 
concentration. Figure Il-lb indicates that the rate of dephosphorylation 
of apophosphorylase a^ is not affected by caffeine, but is still inhibited 
70% by 3 mM AMP, The same results are seen for the dephosphorylation of 
pyridoxal reconstituted phosphorylase a_ as shown in Figure II-lc. If 
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5 mM phosphite is included in the test solution, the rate for dephos-
phorylation of pyridoxal reconstituted phosphorylase a^ is increased 
1.8-fold by 3 mM caffeine. It was suggested previously that phosphite 
binds noncovalently at the site normally occupied by the 5'-phosphate of 
pyridoxal phosphate in phosphorylase a^ (13,18). Thus, it seems that the 
coenzyme is necessary for the response to caffeine and that the 
phosphoryl portion of the coenzyme is particularly important. 
A shift of the dimer-tetramer equilibrium of phosphorylase ^ 
towards the dimer by caffeine has been reported by Bot (38). With 
the conditions used for dephosphorylation. phosphorylase a_ is dissociated 
by 3 mM caffeine to a form of the enzyme with a sedimentation constant 
characteristic of a dimer species (Table II-I). Apophosphorylase ^ is 
present seemingly as a mixture of monomer, dimer, and tetramer (10). 
Caffeine at 3 mf*1 did not change the ultracentrifuge pattern of apophos­
phorylase No dissociation of apophosphorylase a^ could be detected 
even at 30 mM caffeine. Pyridoxal-phosphorylase ^ is not dissociated to 
any appreciable amount by 3 mM caffeine, but it is fully dissociated to 
the dimer by 30 mM caffeine (Table II-I). The dephosphorylation of 
pyridoxal-phosphorylase however, is not activated by 30 mM caffeine. 
Pyridoxal-phosphorylase ^ in the presence of 5 mM phosphite was not 
dissociated by 3 mM caffeine, although as previously mentioned the 
phosphatase reaction is stimulated 1.8-fold under these conditions. 
The ultracentrifugal results indicate that caffeine can bind to 
pyridoxal-phosphorylase, yet the structural change necessary for 
enhancement of the phosphatase reaction does not occur. In the presence 
72 
of phosphite, the pyridoxal reconstituted enzyme shows a stimulation of 
the phosphatase reaction, although this stimulation cannot be correlated 
with changes in the dimer-tetramer equilibrium. We will provide further 
evidence to show that dissociation of phosphorylase ^ is not sufficient 
to explain activation. 
Because our present results and an earlier study (13) suggested 
that the phosphoryl portion of the coenzyme is important for response to 
caffeine and glucose, we examined carefully the effects of modification 
of the 5' position of the coenzyme on phosphorylase a^ structure and 
enzymatic dephosphorylation. Seven pyridoxal phosphate analogs were 
used to reconstitute apophosphorylase a^. The rates of dephosphorylation 
of these enzymes under various conditions are listed in Table II-II. 
The highest rate of dephosphorylation in the absence of effectors is 
seen with native phosphorylase Although kinetic parameters have not 
been established (K^ and values) for the different reconstituted 
phosphorylases, it is clear that all phosphorylases reconstituted with 
analogs are poorer substrates. Also shown in Table II-II are activities 
of the various phosphorylases. These had been reported earlier with 
phosphorylase ^ (3,10,39), None of the enzyme forms without activity 
could be stimilated by glucose or caffeine in the enzymatic dephos­
phorylation test. All active forms except phosphorylase ^ reconstituted 
with a-methylpyridoxal phosphate were stimulated by caffeine and glucose. 
With the a-methylpyridoxal phosphate reconstituted enzyme, no stimulation 
of the dephosphorylation was seen by glucose at the concentration used, 
although stimulation by caffeine was similar to that of the native enzyme. 
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31 From P-NMR studies of phosphorylase (40) and the effects of 
phosphate analogs on the activity of pyridoxal reconstituted phos­
phorylase (18), it was suggested that the state of ionization of the 
phosphoryl portion of the pyridoxal phosphate is important for catalysis. 
All the pyridoxal phosphate analogs used here, that gave activity upon 
reconstitution with apophosphorylase a_, have higher pK values for the 
phosphoryl portion than does pyridoxal phosphate. The pK, values are 
6.20 (41), 6.76 (30), 7.0-7.35 (39,42), and 7.1 (42) for pyridoxal 
phosphate, phosphonomethyl, phosphonoethyl, and phosphonoethenyl analogs 
of pyridoxal phosphate, respectively. Vidgoff et al. (39) showed 
earlier that the pH optimum was shifted to a higher pH for phosphorylase 
reconstituted with the phosphonoethyl analog of pyridoxal phosphate. 
The effect of pH on the activation of enzymatic dephosphorylation by 
caffeine was studied to determine whether the higher pK^ values of 
coenzyme analogs also caused a shift in the pH curve. As shown in 
Figure II-2, caffeine gives the maximum amount of activation to the 
pyridoxal phosphate reconstituted phosphorylase a^ from pH 6.0-6.4 and 
gradually loses the effect at higher pH. For phosphorylase ^ 
reconstituted with phosphonoethyl or phosphonoethenyl analogs of 
pyridoxal phosphate, the maximum stimulation by caffeine is around 
pH 7.6 and pH 8.2, respectively. Thus, the results show generally that 
a shift in the pH optimum to the alkaline side occurs with increasing 
pK values, 
a 
Sedimentation velocity measurements were done on all the phos-
phorylases reconstituted with pyridoxal phosphate analogs reported in 
74 
Table II-II to determine whether activation was correlated with the 
dissociation of phosphorylase All of the analog-reconstituted 
phosphorylases that did not show any response to caffeine or glucose in 
the enzymatic dephosphorylation were also not dissociated by these 
effectors. These forms include phosphorylase ^ reconstituted with 
pyridoxal phosphate methyl ester, deoxypyridoxal, or the carboxyethenyl 
analog of pyridoxal phosphate. All of these proteins have Sgg ^ values 
of about 13 S with or without 3 mM caffeine or 10 mM glucose. Ultra-
centrifugation also was done in high salt solutions since it was shown 
previously that dissociation of native phosphorylase ^ occurs in the 
presence of NaCl (43). As shown in Figure I1-3, the phosphorylase a^ 
reconstituted with the carboxyethenyl analog was not dissociated by 
2.5 M NaCl as compared with the native phosphorylase a^. The former 
sedimented as a single component with an Sgg ^ = 13 S, whereas the 
native enzyme showed a broad peak characteristic of the equilibrium 
between dimeric and tetrameric forms. The sedimentation pattern of 
phosphorylase a reconstituted with pyridoxal phosphate methyl ester 
in 2.5 M NaCl showed some asymmetry indicating some dissociation but 
far less than that of the native enzyme (data not shown). These 
results suggest that the 5' side chain group of the coenzyme has an 
important influence on phosphorylase ^ structure. 
The sedimentation values for reconstituted phosphorylases whose 
dephosphorylations were stimulated by caffeine or glucose are listed 
in Table II-III, Caffeine at 3 mM dissociates phosphorylase a^ 
reconstituted with the phosphonoethyl analog of pyridoxal phosphate 
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to the same extent as that of native phosphorylase ^ (Table II-III, 
Figure II-4a). Phosphorylase ^ reconstituted with the phosphoethenyl 
analog is also dissociated but less effectively (Figure II-4c). 
Caffeine at 3 mM, however, only dissociates slightly the a-methyl-
pyridoxal phosphate reconstituted phosphorylase a^ as revealed by a 
slight broadening of the peak and a change in sedimentation constant, 
$20 ^5 from 13.0 S to 12.3 S (results not shown). For phosphorylase a 
reconstituted with the phosphonomethyl analog, caffeine at 3 mM does 
not show any shift from tetramer to dimer (Table II-III), Glucose at 
10 mM, on the other hand, cannot dissociate any of the reconstituted 
phosphorylases in Table II-III to the extent observed for 
phosphorylase à reconstituted with pyridoxal phosphate. The sedi­
mentation pattern of phosphorylase ^ reconstituted with the phosphono-
ethyl analog is broadened (4b) but little or no effect is seen 
with phosphorylase ^ reconstituted with the phosphonoethenyl analog 
(4d). Also, glucose has little or no effect on the ultracentrifugal 
characteristics of phosphorylases reconstituted with a-methylpyridoxal 
phosphate or the phosphonomethyl analog. There results and those of 
Table II-II suggest that the extent of activation of the phosphatase 
reaction and the dissociation are not exactly correlated. 
One of the possible reasons that glucose at 10 mM did not 
dissociate reconstituted phosphorylases with the phosphonoethenyl or 
phosphonoethyl analogs is that these phosphorylases do not have as 
high an affinity for glucose as does the native phosphorylase à. As 
shown in Table II-IV, the K-j values of glucose for these two 
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reconstituted phosphorylases are higher than those of the native enzyme 
especially that of the phosphorylase a^ reconstituted with the phos-
phonoethenyl analog which is 5-fold higher. Kj values for caffeine are 
elevated two-fold for these reconstituted phosphorylases. These results 
suggest that the 5' side chain function of the coenzyme affects the 
structural integrity of the binding sites for glucose and caffeine and 
could explain the differences seen in the ultracentrifuge for pyridoxal 
phosphate-reconstituted and analog-reconstituted phosphorylases in the 
presence of glucose. Phosphorylase a^ activity was assayed with the 
incorporation of [U-^\]-glucose into glycogen from [U-^\]-glucose-l-
phosphate (44). 
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DISCUSSION 
An important control mechanism in glycogen degradation is the 
enzymatic dephosphorylation of phosphorylase a_. The activators, glucose 
(45-47) and caffeine (36), and the inhibitor, AMP (36), affect dephos­
phorylation by binding to the substrate, phosphorylase a. Our earlier 
results suggested that the coenzyme, pyridoxal phosphate was important 
for the effect of glucose (13). This study shows that the coenzyme is 
also important for activation by caffeine, but it is not essential for 
Af4P inhibition. 
Because AMP binds extremely well to apophosphorylase (.31), it is 
not surprising that it affects enzymatic dephosphorylation. AMP binds 
some 30 Â from the coenzyme site near the phosphorylatable serine while 
glucose and caffeine bind to two distinct sites in close proximity to 
the pyridoxal phosphate site (48). Conceivably the coenzyme could be 
important for the structural integrity of the two sites near it, and 
the lack of effect of glucose and caffeine on enzymatic dephosphorylation 
and on the ultracentrifugal characteristics of apophosphorylase ^ could 
be due to poor binding of these effectors. 
We have found that the phosphoryl group of the coenzyme is 
particularly important for the effects of glucose and caffeine. This 
was first indicated by the fact that pyridoxal, itself, was not 
sufficient to give an enzyme form whose dephosphorylation was activated 
by glucose (13) or by caffeine. However, both glucose and caffeine can 
affect pyridoxal phosphorylase in the presence of inorganic phosphite, 
a phosphate analog believed to bind at the site where the phosphate 
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group of the natural coenzyme resides (18). Second, only phosphorylase 
reconstituted with analogs containing two ionizable hydrogens on the 
5' side chain showed activation of the phosphatase reaction by glucose 
or caffeine. In addition, phosphorylase reconstituted with the 
carboxyethenyl analog of pyridoxal phosphate or pyridoxal phosphate 
methyl ester showed an altered response to NaCl, an agent that readily 
promotes dissociation of the tetramer of phosphorylase a to the dimer 
(43), indicating that important structural differences exist between 
the native enzyme and these phosphorylases. The charge state of the 
phosphoryl function is likely important for response to glucose or 
caffeine. Analogs containing phosphonate functions possess higher 
pK values than does the phosphate group of pyridoxal phosphate and 
require a higher pH value for maximum response to effectors. These 
results suggest that a dianionic form of the coenzyme is important 
for control of dephosphorylation, as was suggested earlier for 
phosphorylase activity (40). 
A relationship seems to exist between the activity of glycogen 
phosphorylase and the response to glucose or caffeine. All analogs 
that are inactive show no response to glucose or caffeine. There is 
no information available that shows whether glucose or caffeine can 
bind to these inactive enzyme forms. All active derivatives show a 
response to 10 mM glucose or 3 mM caffeine except for phosphorylase ^ 
reconstituted with a-methy1pyridoxal phosphate. Differences exist in 
response to these effectors (Table II-IV), and a study is presently 
being done to determine the exact relationship between binding and 
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activation. Our results suggest that the involvement of pyridoxal 
phosphate in catalysis is related to its role in the enzymatic dephos-
phorylation dephosphorylase a in response to glucose and caffeine. 
These two events could occur through a common mechanism, perhaps through 
a proton shuttle, a conformational event, or another process. Some 
phosphorylases do not undergo covalent modification, and the coenzyme is 
evidently necessary just for activity (49,50). Animal phosphorylases, 
however, require pyridoxal phosphate for activity as well as for the 
control of enzymatic covalent modification as shown in this study. 
Caffeine or glucose is known to cause a dissociation of muscle 
phosphorylase ^ from a tetramer to a dimer {38,51). The relationship 
between dissociation and activation of the phosphatase reaction has 
been studied by several investigators (38,45,47,52,53), Bot and his 
associates (38,52,53) suggest that phosphoprotein phosphatase can 
dephosphorylate only the dimeric form. Our results with analogs of 
pyridoxal phosphate show that some dissociation occurs with analogs in 
response to glucose or caffeine. Phosphorylase a reconstituted with 
the phosphonoethenyl analog of pyridoxal phosphate shows very little 
dissociation by glucose while a large effect occurs with native 
phosphorylase a.. The enzymatic dephosphorylation of this phosphonate 
analog under this same condition, pH 7.5, is activated 6-fold, but 
native phosphorylase is activated only 2-fold. Our results suggest 
that other factors besides dissociation of phosphorylase ^ are 
necessary to explain activation of the phosphatase reaction. Madsen 
et al_. (48) have shown that binding of AMP to phosphorylase ^ induces 
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a conformational change in the amino terminal portion of the enzyme which 
moves inward towards a fold in the enzyme, making the serine-14-phosphate 
unavailable to phosphatase. They also suggested that glucose or caffeine 
activation of enzymatic dephosphorylation occurs through a conformational 
change that makes the seryl phosphate more accessible to the phosphatase. 
The extensive study of Hers and his associates has demonstrated 
that glycogen metabolism in vivo is altered by glucose through its 
interaction with phosphorylase ^ (54,55,56,57), This binding promotes 
dephosphorylation of phosphorylase which is then followed by the 
dephosphorylation of glycogen synthase D and glycogen synthesis. 
Kasvinsky et (20) showed that synergistic regulation of phos­
phorylase ^ activity occurs with glucose and caffeine and suggested 
that a combined action involving these two sites might be important in 
the physiological regulation of phosphatase activity. Miller et al. 
(58) showed that control of glycogen synthase and phosphorylase by 
glucose is lost in perfused livers of alloxan-treated diabetic rats 
in vitro. Our results show that regulation of dephosphorylation of 
phosphorylase à by glucose or caffeine is dependent upon pyridoxal 
phosphate. An alteration in the response to glucose or caffeine under 
some physiological conditions might be due to a change in the coenzyme 
state of phosphorylase. Possibly, some apoenzyme is present under 
different physiological conditions although earlier studies did not 
detect apophosphorylase in a vitamin Bg deficiency state (59), Our 
studies show that enzymatic dephosphorylation in response to glucose 
or caffeine is sensitive to pH. Perhaps the effect of pH might be 
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due to changes in the ionic state of the coenzyme in phosphorylase. 
31 However, P-NMR spectroscopy did not show any appreciable change in 
the chemical shift of phosphorylase ^ as a function of pH, but not 
much information is available about phosphorylase ^ (40). pH changes 
or other factors might change the interaction of the 5'-phosphoryl 
group of the coenzyme. Further experimentation is necessary to show 
whether a change in amount or type of binding of pyridoxal phosphate 
in phosphorylase is important in the physiological response to 
glucose and other effectors. 
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Table II-I  
Influence of caffeine and AMP on the sedimentation behavior of different 
forms of phosphorylase ^ 
Sample Sedimentation Constants 
Dimer Tetramer 
Phosphorylase ^ none 14.1 
Phosphorylase a^ + 3 mM caffeine 8.8 none 
Apophosphorylase ^ 6.9 16.0 
Apophosphorylase a_ + 3 mM caffeine 6.6 16.0 
Apophosphorylase ^ + 3 mM AMP none 13.6 
Pyridoxal phosphorylase a none 12.9 
Pyridoxal phosphorylase a_ + 3 mM caffeine none 12.5 
Pyridoxal phosphorylase ^ + 6 mM phosphite none 12.7 
Pyridoxal phosphorylase ^ + 6 mM phosphite + 
3 mM caffeine none 12,5 
Pyridoxal phosphorylase a_ + 30 mM caffeine 9.1 none 
^All protein concentrations are 3 mg/ml in 50 mM Tris, 30 mM 
mercaptoethanol, pH 7.5. Temperature of runs are 23.5 ± 0.5 °C. 
Table II-II  
Effect of caffeine or glucose on the rate of dephosphorylation of native phosphorylase ^ and analog 
reconstituted phosphorylases® 
Name 
1-UO Rate of Activity of 
Caffeine Glucose dephosphorylation reconstituted . 
{ 2  nil) (10 mM) (nmol released/min) phosphorylase à 
Pyridoxal phosphate 
Deoxypyridoxal 
a-Methylpyridoxal 
phosphate 
Pyridoxal phosphate 
methyl ester 
-CHgOPOgHg 
-CH. 
-CHtCHgjOPOgHr 
-CHgOPOgtCHgiH 
0,123 
0.214 
0.251 
0.051 
0.052 
0.051 
0.051 
0.109 
0.051 
0.034 
0.034 
0.034 
100% 
none 
less than 1% 
none 
The experimental procedure was identical to that described in Figure II-l. All protein 
substrate concentrations are 3 mg/ml. 
'^Expressed as percent of that of pyridoxal phosphate reconstituted phosphorylase a^ which is 
66 lU/mg, assayed with 1 mM AMP. 
Table II-II .  (Continued) 
H^O 
un jL R Rate of Activity of 
Name R Caffeine Glucose dephosphorylation reconstituted . 
H^C'^fr (2 mM) (10 mM) (nmol released/min) phosphorylase ^ 
Phosphonomethyl analog of 
pyridoxal phosphate -CHLPOgHL - - 0.033 3% 
+ - 0.074 
+ 0.074 
Phosphonoethyl analog 
of pyridoxal 
phosphate -CHLCH.POnH. - - 0.067 43% 
^ ^ ^ + _ 0.223 
+ 0.280 
Phosphonoethenyl analog 
of pyridoxal 
phosphate -CI-NCHPOoHp (Trans) - - 0.034 16% 
^ + - 0.190 
+ 0.118 
Carboxyethenyl analog 
of pyridoxal 
phosphate -CH=CHCO«H (Trans) - - 0.024 none 
+ - 0,024 
+ 0.024 
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Table II-III  
Sedimentation values of phosphorylase ^ derivatives in the presence of 
glucose or caffeine^ 
Pyridoxal phosphate analogs Effectors 
used to reconstitute Caffeine Glucose Sedimentation 
apophosphorylase a_ (3 mM) (10 mM) Constant 
a-Methyl pyrodoxal phosphate - - 13.0 
+ 13.1 
+ - 12.3 
Phosphonoethyl analog - - 13.3 
+ 12.3 
20 mM 10.0 
+ - 8.0 
Phosphonoethenyl analog - - 13.0 
+ 12.7 
+ -  8.6 
Phosphonomethyl analog - - 13.2 
+ 13.0 
+ - 12.9 
^All protein concentrations are 3 rag/ml in 50 mM Tris, 30 mM 
mercaptoethanol, pH 7.5. Temperature of runs are 22 ± 0.5°C. 
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Table II-IV 
Comparison of Kj values of glucose and caffeine for active phosphorylase 
reconstituted with pyridoxal analogs® 
Analogs used to reconstitute Kj for Kj for 
apophosphorylase a glucose (mM) caffeine (mM) 
Pyridoxal phosphate 6 0.32 
Phosphonoethenyl analog 30 0.65 
Phosphonoethyl analog 12 0.65 
Kj values were obtained by measuring activities in the presence of 
1% glycogen, 1 mM AMP, 50 mM Tris, 15 mM mercaptoethanol, with 
glucose-1-phosphate concentrations between 1.68 and 10 mM, caffeine 
concentrations between 0.5 and 2 mM, or glucose concentrations between 
5 and 30 mM, at pH 7.5 and 30°C. The incorporation of [U-'^Cj-glucose 
into glycogen from [U-'^C]-glucose-l-phosphate was followed utilizing 
the filter paper assay of Thomas et (44). 
Figure II-l. The effect of caffeine and AMP on the dephosphorylation of different 
32 forms of P-phosphorylase ^ by phosphoprotein phosphatase. 3 mg/ml 
Of native phosphorylase & (a); or apophosphorylase a (b); or 
pyridoxal-reconstituted phosphorylase ^ (c): or pyridoxal-reconstituted 
phosphorylase ^ + 6 mM phosphite (d); was used as substrate. Final 
volume of reaction mixture was 0.5 ml, with 50 mM Tris, 30 mM 
mercaptoethanol, pM 7,5, as buffer containing (D) 3 mM caffeine, 
(A) 3 mM AMP or ( O ) no addition. The reaction was initiated 
with 0.1 units of phosphoprotein phosphatase at 30°C (25). At 
different intervals, 100 yl of the reaction mixture was removed and 
stopped by 200 yl of 30% trichloroacetic acid and 100 yl of 
20 mg/ml bovine serum albumin. After filtering through glasswool, 
an aliquot was taken and counted as described in Materials and 
Methods. 
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Figure II-2. Effect of pH on the activation of the dephosphorylation of 
phosphorylase a^ derivatives by caffeine. The dephosphorylation 
32 ^ 
of P-phosphorylase ^ reconstituted with (Q) pyridoxal phosphate, 
( • )  p h o s p h o n o e t h y l ,  ( Q )  p h o s p h o n o e t h e n y l ,  ( A )  p h o s p h o n o m e t h y l  
analogs of pyridoxal phosphate at different pH's in the presence of 
3 niM caffeine is shown. Procedure is the same as that described in 
the legend of Figure II-l, except that 100 mM imidazole, 100 mM 
Tris, 30 mM mercaptoethanol buffer is used. The activation by 
2 mM caffeine at different pH's is plotted against pH. 
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Figure I1-3. Effect of NaCl on the ultracentrifugal patterns of 
phosphorylase reconstituted with pyridoxal phosphate 
and its carboxyethenyl analog. Top, pyridoxal phosphate 
reconstituted phosphorylase a^ with 2.5 M NaCl; bottom, 
carboxyethenyl analog reconstituted phosphorylase a_ 
with 2.5 M NaCl. Protein concentrations were 3 mg/ml 
in 50 mM Tris, 30 mM mercaptoethanol, pH 7.5, at 16°C. 
The picture was taken 48 minutes after attaining full 
speed of 52,000 rpm. 
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Figure II-4. Effect of glucose and caffeine on the ultracentrifugal 
patterns of phosphorylase ^ derivatives, a) Top, 
phosphonoethyl analog; bottom, phosphonoethyl analog 
and 3 mM caffeine; b) top, phosphonoethyl analog; 
bottom, phosphonoethyl analog and 10 mM glucose; 
c) top, phosphonoethenyl analog; bottom, phosphono-
ethenyl analog and 3 mM caffeine; d) top, phosphono­
ethenyl analog; bottom, phosphonoethenyl analog and 
10 mM glucose. All protein concentrations were 
3 mg/ml in 50 mM Tris, 30 mM mercaptoethanol, 
pH 7.5, at 22°C. The pictures were taken 39 
minutes.(a), 30 minutes (b), 44 minutes (c), and 
34 minutes (d), after attaining full speed of 
52,000 rpm. 
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DISCUSSION 
Phosphoprotein phosphatase activity was first discovered more than 
thirty-five years ago in connection with glycogen metabolism studies. 
Not much is known about phosphoprotein phosphatase after all these 
years. However, due to its wide substrate specificities, it is 
believed to be very important in the regulation of many cellular 
functions. Thus, in this dissertation, one of the objectives is to 
study the regulation of the catalytic subunit of phosphoprotein 
phosphatase. Since polyphosphate compounds were found to be active 
site directed inhibitors for phosphoprotein phosphatase, they were 
examined in detail to provide insight about the active site of the 
phosphatase. The inactivation of the phosphoprotein phosphatase by 
ATP or PPi is probably not by hydrolysis of these compounds because 
analogs of ATP or PPi, adenyly (g,y-methylene) diphosphonate, and 
methylene diphosphonate, respectively, are also inhibitors of this 
phosphatase. The fact that ATP or PPi inactivated phosphatase can 
2+ 2+ be reactivated only by Mn or Co , and not by other cationic compounds 
suggests strongly that the phosphoprotein phosphatase can be a 
metalloprotein. However, from metal analysis of the phosphatase, 
no significant amount of metal ions would be detected. Most 
2+ 2+ 
notably Mn or Co which activated the enzyme were absent. This 
result was based entirely on the assumption that this author was 
working with a Mr=35,000 phosphatase that was purified to near 
homogeneity. It was only after the metal analysis experiments that 
this author found out that there was a contaminating p-nitrophenyl 
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phosphatase activity in the phosphoprotein phosphatase preparation. 
Experimental evidence showed that p-nitrophenyl phosphatase activity 
and the phosphoprotein phosphatase activity could be separate entities. 
Preliminary data (not included in this dissertation) indicate that 
the two activities can be partially separated on a phosphorylase 
sepharose 4B column. Recently, Li ^ al_. (103) also reported the 
copurification of alkaline phosphatase with the Mr=35,000 phospho­
protein phosphatase of dog cardiac muscle. The contaminating alkaline 
2+ phosphatase requires Mg and sulfhydryl reagents for activity and can 
be partially separated from the phosphoprotein phosphatase by a 
sepharose C1-4B column. Thus, the Mr=35,000 catalytic subunit of 
phosphoprotein phosphatase must be purified further to get rid of 
the p-nitrophenyl phosphatase. Some experiments in this dissertation 
will have to be extended. The biphasic kinetics of the inactivation 
of the phosphatase by ATP or PPi may be due to 2 different 
phosphatases affected differently by these polyphosphate compounds, 
32 [ P-Y]ATP labelling experiment and metal analysis of the purified 
phosphoprotein phosphatase should also be done on purer preparations. 
Not much progress on the chemical and physical properties of 
phosphoprotein phosphatase can be made unless purity and yield of the 
phosphoprotein phosphatase preparation is improved. 
One of the ways to regulate the multifunctional phosphatase is 
through substrate directed effects. To study the substrate directed 
effects, glycogen phosphorylase a as a substrate for the phosphatase 
can be a very good model system for several reasons. First, there 
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is only one phosphate per monomer of the phosphorylase ^ molecule and 
therefore it is less complex than other substrates such as glycogen 
synthase which is a multi-site phosphorylated protein. Second, the 
sequence of phosphorylase molecule is worked out by Titani et al. 
(104); third, the x-ray crystallography of the phosphorylase a_ 
molecules is reported to 2,5 Â by Fletterick and coworkers (105-106); 
and fourth, by difference maps of various conformers as induced by the 
binding of ligands, movements of individual residues in the 
phosphorylase ^ molecule during the transitions can be inferred. 
The phosphorylase ^ molecule examined by x-ray crystallography 
is a dimer with 2 identical subunits. Each monomer is made up of a 
N-terminal domain consisting of 489 amino acids and a C-terminal 
domain with 352 residues. The 2 monomers overlap each other at the 
N-terminal domains with a 2-fold symmetry axis. The dimer has a 
concave surface which is the catalytic face with the active site, 
the negative effector site and the glycogen storage site. Directly 
opposite to this face is a convex surface which is the controlling 
face where the interconverting enzymes, phosphorylase kinase and 
phosphoprotein phosphatase bind. Thus, there are the Ser 14 
phosphate and the AMP site at the controlling face, and they are 
close together at the N-terminus. Some 40 A from the AMP site is the 
active site where the coenzyme pyridoxal phosphate and the substrate 
glucose-1-phosphate bind. The active site is between the 2 domains 
of the monomer. At 10 Â from the active site is the negative 
effector site where caffeine binds. Residue 50 to 75 is a long helix 
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and the C-terminal end of it forms part of the AMP site. When AMP 
binds, the whole helix moves toward the center of the monomer by 5°A. 
Arg 69 of this helix is H-bonded to the Ser 14 phosphate. Thus, AMP 
causes the Ser 14 phosphate also to move inward, and thus inhibits 
the dephosphorylation of phosphorylase ^ by phosphoprotein phosphatase. 
Glucose at the active site or caffeine at the negative effector site 
induces a major conformational change at the N-terminal region of each 
of the monomers. Residues 284 and 285 which are H-bonded to glucose 
and caffeine, respectively, are part of an extended loop which joins 
a long helix, residues 290-313, the C-terminal end of which extends 
towards the N-terminus forming part of the AMP site. Thus, glucose 
and caffeine, even though they bind some 40°A away from the Ser 14 
phosphate, can stimulate the dephosphorylation of phosphorylase a^ 
by phosphoprotein phosphatase. The synergistic effect of glucose 
and caffeine on the dephosphorylation of phosphorylase a^ (107) can 
be explained on the basis that 2 adjacent residues 284 and 285 are 
in close contact with the two ligands. The binding of one ligand 
can affect the other by movement of the peptide backbone. The 
coenzyme pyridoxal phosphate is shown in this dissertation to 
influence the effect of caffeine and glucose on the dephosphorylation 
of phosphorylase By looking at the x-ray crystallography map, 
one can attempt to explain how this occurs. The coenzyme is 
covalently attached to phosphorylase via shift base with the e-NHg 
group of Lys 679. The adjacent residues 671-674 are all in close 
contact with the glucose molecule. So they may form part of the 
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recognition site for glucose. Thus, proper orientation or intactness of 
the coenzyme can affect the binding of glucose. Similarly, residue Lys 
567 is H-bonded with the phosphate of the coenzyme. Adjacent residues 
570 and 571 are H-bonded to caffeine at the negative effector site. 
Thus, the function of the coenzyme is to serve as an anchor for the 
correct formation of glucose and caffeine binding sites. 
Graves ^ al_. (108) have compared the kinetics of phosphatase 
action on the tetradecapeptide containing residues 5 to 18 of the 
phosphorylase a_ sequence with that of the natural substrate. While 
the Vm for the two substrates was equivalent, the Km for 
phosphorylase ^ was 5 yM while that for the peptide was 1 mM. It is 
apparent that the phosphatase recognizes a much more extensive binding 
domain on the surface of the phosphorylase ^ molecule than that 
provided by the residues in the peptide sequence adjacent to the 
scissile phosphate bond. X-ray crystallography (106) shows that there 
is a ring of positive charges around the Ser 14 phosphate. These 
positive charges are formed by 9 lysine or arginine residues and 
2 histidine residues with part of these residues contributed by the 
symmetry related monomer. Part or all of the ring of positive charges 
can form a recognition or binding site for the phosphorylase-
phosphatase interaction. Kinetic studies have shown that AMP and 
glucose affect the Vmax of the dephosphorylation of phosphorylase a 
by phosphatase with little change in the Km (66,109), Thus, it seems 
that the phosphatase binds equally well to all these different con-
formers. It is possible that the phosphatase undergoes a complementary 
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structural change or recognizes different features in the various 
conformers. Another possible explanation is that with the exception 
of a change in accessibility of Ser 14 phosphate to phosphatase, 
the recognition site has nearly the same structure in all of these 
conformers. X-ray data presented so far cannot distinguish between 
these possibilities. Presently, I am investigating the conformational 
change of the phosphorylase ^ molecule in the presence of different 
ligands under a dynamic state, to test the above alternatives. This 
is approached by the method of competitive labelling as described 
by Kaplan et (110). The principle is that in the presence of a 
3 trace amount of H-acetic anhydride, the lysine residues in the 
protein molecule will compete for the label and the amount incorporated 
into each lysine will be determined by its nucleophilicity, pK, and 
micro-environment. Afterwards, under denaturing conditions, the 
protein is completely labelled with an excess of nonradioactive 
acetic anhydride. The result is a chemically homogeneous, but heter-
geneously labelled protein molecule, the specific radioactivity of 
each lysine being related to its reactivity and accessibility in the 
native protein conformation. 
As mentioned above, each of the two Ser 14 phosphates of a dimer 
of phosphorylase a is surrounded by a ring of positive charges. Part 
of the ring of positive charges is contributed by the monomer which 
is symmetry related to the one containing Ser 14 phosphate. Would 
the removal of a phosphate from one monomer affect the conformation of 
the other phosphorylated monomer? The two Ser 14 phosphates in the 
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dimer are 40 A apart. The phosphoprotein phosphatase probably does not 
dephosphorylate both of them before acting on another dimer. Hurd et al. 
(Ill) observed formation of partially dephosphorylated intermediates in 
the interconversion of phosphorylase a_ to Preliminary data from 
this work have shown that there is a lag in the dephosphorylation of 
phosphorylase a at pH below 7.6 and at high phosphorylase à 
concentration (3 mg/ml). Both the high concentration and lower pH 
tend to shift the equilibrium of tetramer-dimer of phosphorylase a^ 
towards the tetramer forms (112). Glucose or low concentration 
(0.2 mg/ml) of phosphorylase ^ eliminates the lag in the dephos­
phorylation of phosphorylase All these seem to attribute the lag 
to the tetramer of phosphorylase a being a poorer substrate for the 
phosphatase. Experiments will be carried out further to try to under­
stand the lag and determine whether hybrid states are formed. 
The study of the phosphorylase molecule becomes even more 
exciting since the x-ray crystallography data are now available at 
2.5 Â. This enables us to see how metabolites change the secondary 
and textiary structure of the phosphorylase at the molecular level. 
Information on how the conformation of the substrate phosphorylase a_ 
affects the phosphatase reaction will be invaluable to extend to 
other phosphoprotein substrates of the phosphatase that are involved 
in other aspects of cellular metabolism. 
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